Free Trial

Vicarious Surgical (NYSE:RBOT) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Vicarious Surgical logo with Medical background

Vicarious Surgical (NYSE:RBOT - Get Free Report) announced its earnings results on Monday. The company reported ($2.58) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.61) by $0.03, Zacks reports.

Vicarious Surgical Price Performance

Shares of RBOT traded up $0.24 during mid-day trading on Friday, hitting $7.43. The stock had a trading volume of 13,547 shares, compared to its average volume of 33,983. Vicarious Surgical has a 52 week low of $4.27 and a 52 week high of $19.00. The business has a fifty day moving average price of $7.09 and a 200-day moving average price of $10.68. The firm has a market cap of $44.07 million, a P/E ratio of -0.72 and a beta of 1.46.

Analyst Ratings Changes

Separately, Piper Sandler dropped their target price on shares of Vicarious Surgical from $10.50 to $8.50 and set a "neutral" rating on the stock in a research note on Tuesday, March 18th.

Read Our Latest Analysis on Vicarious Surgical

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Further Reading

Earnings History for Vicarious Surgical (NYSE:RBOT)

Should You Invest $1,000 in Vicarious Surgical Right Now?

Before you consider Vicarious Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vicarious Surgical wasn't on the list.

While Vicarious Surgical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines